AZD3229   Click here for help

GtoPdb Ligand ID: 12703

Synonyms: AZD-3229
PDB Ligand
Compound class: Synthetic organic
Comment: AZD3229 is a lead dual KIT/PDGFRα inhibitor [1]. It was designed for potential to treat gastrointestinal stromal tumours driven by mutations in KIT or platelet-derived growth factor α (PDGFRα).
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 10
Hydrogen bond donors 2
Rotatable bonds 11
Topological polar surface area 112.27
Molecular weight 479.51
XLogP 0.35
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)C1=CN(CC(=O)NC2=CC=C(C=C2)NC3=C4C(=CC(=CC4=NC=N3)OCCOC)F)N=N1
Isomeric SMILES FC1=C2C(N=CN=C2NC3=CC=C(NC(CN4C=C(C(C)C)N=N4)=O)C=C3)=CC(OCCOC)=C1
InChI InChI=1S/C24H26FN7O3/c1-15(2)21-12-32(31-30-21)13-22(33)28-16-4-6-17(7-5-16)29-24-23-19(25)10-18(35-9-8-34-3)11-20(23)26-14-27-24/h4-7,10-12,14-15H,8-9,13H2,1-3H3,(H,28,33)(H,26,27,29)
InChI Key FLJOFQUXYAWOPE-UHFFFAOYSA-N
References
1. Banks E, Grondine M, Bhavsar D, Barry E, Kettle JG, Reddy VP, Brown C, Wang H, Mettetal JT, Collins T et al.. (2020)
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors.
Sci Transl Med, 12 (541). [PMID:32350132]